Clinical Trials Directory

Trials / Completed

CompletedNCT06312488

Point of Care Evaluation of Fibrinolysis in Sepsis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Policlinico Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Impaired fibrinolysis in septic patients is associated with worse outcome. The present study investigates fibrinolysis shutdown in septic patients, defined as prolonged ClotPro® TPA lysis time at 30 minutes. The TPA lysis time reference range is established in a cohort of healthy volunteers.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTClot ProThis study enrolls patients admitted to the Adult ICU of Milan Policlinico Hospital with a diagnosis of sepsis or septic shock. A ClotPro® TPA test is performed at admission and on day 1, 2, 3, and 7. Specific markers of coagulation (PAI-1, Plasminogen, Protein C and S) and inflammation (Il-1beta, IL-6, IL-8, TNF-alpha, ADM) are tested at enrollment. Routine laboratory tests are performed daily. Hemorrhagic and thrombotic events are searched. The study ends at 28 days or upon ICU discharge.

Timeline

Start date
2024-01-22
Primary completion
2025-03-31
Completion
2025-11-30
First posted
2024-03-15
Last updated
2026-04-08

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06312488. Inclusion in this directory is not an endorsement.